SE8702843D0 - NEW USE OF BROMOCRIPTINE - Google Patents

NEW USE OF BROMOCRIPTINE

Info

Publication number
SE8702843D0
SE8702843D0 SE8702843A SE8702843A SE8702843D0 SE 8702843 D0 SE8702843 D0 SE 8702843D0 SE 8702843 A SE8702843 A SE 8702843A SE 8702843 A SE8702843 A SE 8702843A SE 8702843 D0 SE8702843 D0 SE 8702843D0
Authority
SE
Sweden
Prior art keywords
bromocriptine
new use
disease
autoimmune
grave
Prior art date
Application number
SE8702843A
Other languages
Swedish (sv)
Other versions
SE8702843L (en
Inventor
D Larson
P Hiestand
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8702843D0 publication Critical patent/SE8702843D0/en
Publication of SE8702843L publication Critical patent/SE8702843L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bromocriptine is used in the treatment of Myasthenia gravis, endocrine opthalmopathy, Grave's disease, Juvenile diabetes, Glomerulonephritis, SLE, Autoimmune hematological disorder, MS and Autoimmune inflammatory bowel disease.
SE8702843A 1986-07-14 1987-07-13 NEW USE OF BROMOCCRIPTIN SE8702843L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88511086A 1986-07-14 1986-07-14

Publications (2)

Publication Number Publication Date
SE8702843D0 true SE8702843D0 (en) 1987-07-13
SE8702843L SE8702843L (en) 1988-01-15

Family

ID=25386156

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8702843A SE8702843L (en) 1986-07-14 1987-07-13 NEW USE OF BROMOCCRIPTIN

Country Status (13)

Country Link
JP (1) JPS6323817A (en)
KR (1) KR880001292A (en)
AU (1) AU602154B2 (en)
CH (1) CH672987A5 (en)
DE (1) DE3722383A1 (en)
DK (1) DK363887A (en)
FR (1) FR2601245A1 (en)
GB (1) GB2192541B (en)
IT (1) IT1224222B (en)
NL (1) NL8701631A (en)
PH (1) PH24525A (en)
SE (1) SE8702843L (en)
ZA (1) ZA875145B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814521A1 (en) * 1987-05-07 1988-11-17 Sandoz Ag NEW APPLICATION OF DOPAMINE RECEPTOR AGONISTS
EP0327040A3 (en) * 1988-02-05 1990-11-28 Predrag Dr.Sc. Sikiric Use of dopamine and/or dopamine agonists to prepare a medicine for the treatment of the digestive tract
US5830895A (en) * 1988-05-10 1998-11-03 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods for the determination and adjustment of prolactin daily rhythms
US5744477A (en) * 1988-05-10 1998-04-28 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for treatment of obesity using prolactin modulators and diet
US6004972A (en) * 1988-05-10 1999-12-21 The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of type II diabetes
US5700800A (en) * 1988-05-10 1997-12-23 Ergo Science Incorporated Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
US5585347A (en) * 1988-05-10 1996-12-17 Ergo Science Incorporated Methods for the determination and adjustment of prolactin daily rhythms
US5468755A (en) * 1988-05-10 1995-11-21 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of Type II diabetes
US5716932A (en) * 1988-05-10 1998-02-10 Louisiana State University And Agricultural And Mechanical College Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
RU2104698C1 (en) * 1991-12-23 1998-02-20 Дзе Борд оф Сьюпервайзорз оф Луизиана Стейт Юниверсити энд Эгрикалчурал энд Мекэникал Колледж Method of treatment of pathological deviations at diabetes mellitus of type-2
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
US5626860A (en) * 1995-06-07 1997-05-06 The Board Of Supervisors Of Louisana State And Agricultural And Mechanical College Method for regulating metabolism with dopamine beta hydroxylase inhibitors
US5714519A (en) * 1995-06-07 1998-02-03 Ergo Science Incorporated Method for regulating glucose metabolism
US20010016582A1 (en) 1997-04-28 2001-08-23 Anthony H. Cincotta Method and composition for the treatment of lipid and glucose metabolism disorders
RU2463048C2 (en) * 2006-11-23 2012-10-10 Эргонекс Фарма Гмбх Pharmaceutical compositions for treating capillary arteriopathy
ES2897475T3 (en) * 2016-04-20 2022-03-01 Veroscience Llc Composition and method for the treatment of metabolic disorders
WO2019079623A1 (en) 2017-10-18 2019-04-25 Veroscience Llc Improved bromocriptine formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (en) * 1968-05-31 1971-05-15 Sandoz Ag Process for the preparation of 2-bromo-a-ergocryptine
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
CH666406A5 (en) * 1984-02-29 1988-07-29 Sandoz Ag METHOD FOR PRODUCING microcapsules BROMOKRIPTINMESYLAT AS PHARMACOLOGICAL ACTIVE INCLUDED.

Also Published As

Publication number Publication date
PH24525A (en) 1990-07-18
GB2192541B (en) 1990-05-02
GB8716323D0 (en) 1987-08-19
DK363887D0 (en) 1987-07-13
GB2192541A (en) 1988-01-20
FR2601245A1 (en) 1988-01-15
JPS6323817A (en) 1988-02-01
KR880001292A (en) 1988-04-22
SE8702843L (en) 1988-01-15
ZA875145B (en) 1989-02-22
NL8701631A (en) 1988-02-01
DK363887A (en) 1988-01-15
DE3722383A1 (en) 1988-01-28
IT8748160A0 (en) 1987-07-10
CH672987A5 (en) 1990-01-31
IT1224222B (en) 1990-09-26
AU602154B2 (en) 1990-10-04
AU7558787A (en) 1988-01-21

Similar Documents

Publication Publication Date Title
SE8702843D0 (en) NEW USE OF BROMOCRIPTINE
FR2543959B1 (en) COPOLYMER SUITABLE FOR THE PREPARATION OF SOFT CONTACT LENSES AND CONTAINING WATER
NO873351D0 (en) HAIR CLEANER MIXTURE AND USE OF THIS.
IT1227064B (en) FLUORINATED POLYURETHANE, CONTAINING POLYOXYPERFLUOROALKYLENE BLOCKS WITH IMPROVED MECHANICAL PROPERTIES
BR8704628A (en) USE OF POLIOIS OR MIXTURES OF POLIOIS
ES1000941Y (en) KEY RING WITH REMOVABLE PEN
GB8720604D0 (en) Speech coding
AR245190A1 (en) Process for preparation of overbased petroleum oxidates, the obtained overbased petroleum oxidates and their use
GB8611205D0 (en) Determination of antigen
FR2595219B1 (en) COMPACT AND MULTIFUNCTIONAL MAKEUP KIT
AU8192987A (en) Human ldh-c4 cdna sequences encoding antigenic regions
ZA872754B (en) Electrochemical reduction of iodopolyfluoroalkanes and fluorinated compounds thereby obtained
GB8706726D0 (en) Determination of water
KR900701276A (en) Use of PAF-antagonists for the treatment of autoimmune diseases
SE8705060L (en) ANTI-COOLING KIT, ANTI-COOLING PREPARATION AND USE OF IT
DK406487A (en) HYDROGEN RING
EP0272285A4 (en) Acylation and sulfonation of silylketene acetals.
ZA873391B (en) Chlorination of water
KR870015953U (en) Key ring with compass
IT8982515A0 (en) FUNCTIONAL STRUCTURE FOR USER ENTRY INTO THE ALPHABETICAL ORDER OF THE DICTIONARY.
AU7985687A (en) Manual interface combined with the use of electronic digital character coding system
KR870018812U (en) Siiso Onov using elasticity of main body case
ES1000746U (en) Case for cigars (Machine-translation by Google Translate, not legally binding)
ES270669U (en) Bath. (Machine-translation by Google Translate, not legally binding)
GB8602186D0 (en) Remote user interface

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8702843-7

Effective date: 19920201

Format of ref document f/p: F